期刊文献+

注射用替考拉宁的组分分析 被引量:6

Component content analysis of teicoplanin for injection
下载PDF
导出
摘要 目的采用高效液相色谱法测定4个厂家生产的注射用替考拉宁的组分含量,比较其异同;采用微生物检定法测定效价,初步探讨替考拉宁的组分与活性的关系。方法色谱柱为TSK-GEL ODS-100V(3),4.6mm×150mm;流动相为磷酸盐缓冲液-乙腈,梯度洗脱;流速1.8mL/min;柱温40℃;检测波长254nm。培养基为抗生素检定用I号培养基,pH7.8~8.0;灭菌缓冲液为磷酸盐缓冲液,pH6.0;试验菌为枯草芽孢杆菌[CMCC(B)63501];高、低浓度分别为20U/mL和10U/mL。结果 4个厂家的产品的TA2-1和TA2-3的含量差异不大,但TA2-2、TA2-4和TA2-5的含量有较大差异;TA2-4和TA2-5的含量较高的产品的活性较高。结论替考拉宁的组分与活性的关系密切,研究者可据此对注射用替考拉宁进行有效的质量控制。 Objective To compare the component content of teicoplanin for injection provided by four manufactures and make preliminary study on the relationship between component content and potency,an HPLC method and microbiological assay were used.Methods A C18 column(TSK-GEL ODS-100V(3),4.6mm×150mm) was used,and the mobile phase was phosphate buffer-acetonitrile with gradient elution.The flow rate was 1.8mL/min.The column temperature was kept at 40℃,and the detection wavelength was set at 254nm.For microbiological assay,medium No.I,pH7.8~8.0 and sterile phosphate buffer,pH6.0 were used.The test organism was Bacillus subtilis [CMCC(B)63501],and the high and low doses of teicoplanin were 20 and 10U/mL respectively.Results Among different products,no obvious difference was shown in contents of TA2-1 and TA2-3,but there were significant differences in contents of TA2-2,TA2-4 and TA2-5,and the products with higher contents of TA2-4 and TA2-5 shown higher potency.Conclusion The relationship between component content and potency of tecoplanin is closely,so that the quality of the products could be controlled effectively.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第11期848-851,872,共5页 Chinese Journal of Antibiotics
关键词 替考拉宁 组分 高效液相色谱法 效价 微生物检定法 Teicoplanin Component content HPLC Potency Microbiological assay
  • 相关文献

参考文献4

二级参考文献37

  • 1夏振强,古勇,官家发.糖肽类抗生素替考拉宁研究进展[J].天然产物研究与开发,2005,17(2):247-252. 被引量:28
  • 2何礼贤,潘珏,陈世耀,王爱霞,谢灿茂,申正义.替考拉宁治疗革兰阳性球菌感染的临床研究[J].中华内科杂志,2005,44(5):337-341. 被引量:29
  • 3田敏,俞朵,刘瑜.替考拉宁产生菌——替考游动放线菌吉安变种的分类鉴定[J].中国抗生素杂志,1996,21(6):401-405. 被引量:4
  • 4王明蓉,丁洪,胡宇杰.精氨酸和缬氨酸在替考拉宁生物合成中的作用[J].中国抗生素杂志,1996,21(A00):77-80. 被引量:10
  • 5纪淳安.Antibacterial activity and clinical application of teicoplanin[J].国外医药:抗生素分册,2001,22(3):122-124.
  • 6Gholizadeh Y, Courvalin Patrice. Acquired and intrinsic glycopeptide resistance in enterococci. International Journal of Antimicrobial Agents, 2000,16: S11-S17.
  • 7Somma S, Gastaldo L, Corti A. Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. Sp. Antimicrobial Agents& Chemotherapy, 1984,26(6) :917-923.
  • 8Corti A, Soffientini A, Cassani G. Binding of the glycopeptide antibiotic teicoplanin to D-alanyl-D-alanine-agarose: the effect of micellar aggregates. Journal of Applied Biochemistry, 1985,7(2): 133-137.
  • 9Jin ZH, Wang MR, Cen PL. Production of teicoplanin by valine analogue-resistant mutant strains of Actinoplanes teichomyceticus . Applied Microbiology and Biotechnology,2002,58:63-66.
  • 10Lee JC,Park HR, Park DJ, et al. Improved production of teicoplanin using adsorbent resin in fermentations. Letters in Applied Microbiology, 2003 ,37(3): 196-200.

共引文献34

同被引文献47

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部